New blood test aims to spot liver cancer early, saving lives from 'silent killer'
NCT ID NCT05971108
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 27 times
Summary
This study tests a new blood test called Elecsys GAAD in 600 people with liver cirrhosis, who are at high risk for liver cancer. The goal is to see if the test finds cancer earlier than current methods, reduces false alarms, and helps more people stick with regular check-ups. If successful, it could lead to earlier treatment and better survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Manchester University NHS Foundation Trust
RECRUITINGManchester, Greater Manchester, M13 9WL, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.